NIP
LLY icon

Nicholas Investment Partners’s Eli Lilly LLY Stock Holding History

Nicholas Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,304
Closed -$1.2M – 256
2017
Q1 		$1.2M Buy
+14,304
New +$1.15M 0.08% 235

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nicholas Investment Partners's LLY Position: Q2 2017 in Review

Nicholas Investment Partners sold out of Eli Lilly (LLY) in Q2 2017, closing a stake of 14,304 shares — an estimated $1.2M sold.

Nicholas Investment Partners first reported a position in LLY in Q1 2017 and held it in 1 quarter. The position peaked at $1.2M in Q1 2017. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Nicholas Investment Partners reported no remaining Eli Lilly position as of Q2 2017 after selling out during the quarter.
  • Nicholas Investment Partners sold 14,304 Eli Lilly shares in Q2 2017, an estimated $1.2M.
  • Nicholas Investment Partners first reported a position in Eli Lilly in Q1 2017 and held it in 1 quarter.
  • Nicholas Investment Partners's Eli Lilly position peaked at $1.2M in Q1 2017.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Nicholas Investment Partners's 13F filing for Q2 2017, filed 11 Aug 2017.